FoodDec 18, 2024
4 Earth Farms formerly Mcl Fresh Organic Vegetable Medley recall — FDA F-0276-2025
potential contamination with E. coli O121:H19
Class IFDA: Terminated4 Earth Farms formerly Mcl Fresh Inc.
Latest records
Latest recalls — page 199
The newest recall records with useful source details are listed here.
FoodDec 18, 2024
Joseph Epstein Food Enterprises, Inc. dba Hungryroot Ricotta Stuffed Shells, 6 packs of 14 recall — FDA F-0283-2025
Products have the potential to be contaminated with Listeria monocytogenes.
Class IIFDA: TerminatedJoseph Epstein Food Enterprises, Inc. dba MamaMancini's
FoodDec 18, 2024
4 Earth Farms formerly Mcl Fresh Organic Carrots recall — FDA F-0280-2025
potential contamination with E. coli O121:H19
Class IFDA: Terminated4 Earth Farms formerly Mcl Fresh Inc.
FoodDec 18, 2024
Joseph Epstein Food Enterprises, Inc. dba Mama Mancini s Stuffed Shells with Sauce and recall — FDA F-0282-2025
Products have the potential to be contaminated with Listeria monocytogenes.
Class IIFDA: TerminatedJoseph Epstein Food Enterprises, Inc. dba MamaMancini's
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 25 mcg recall — FDA D-0123-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 75 mcg recall — FDA D-0125-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Timolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles recall — FDA D-0114-2025
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Class IIFDA: OngoingFDC Limited
DrugDec 18, 2024
Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials recall — FDA D-0116-2025
cGMP Deviations: Temperature excursion
Class IIFDA: TerminatedMckesson Medical-Surgical Inc. Corporate Office
DrugDec 18, 2024
Biocompatibles UK Varithena recall — FDA D-0113-2025
Defective Delivery System: incorrect silicone oil-free NormJect 10 mL Luer Lock Solo syringes packaged in the pack, instead of the required silicone oil-free NormJect 10 mL Luer Solo…
Class IIIFDA: TerminatedBiocompatibles UK, Ltd.
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 88 mcg recall — FDA D-0126-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 137 mcg recall — FDA D-0119-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 175 mcg recall — FDA D-0121-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 112 mcg recall — FDA D-0128-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton recall — FDA D-0134-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 200 mcg recall — FDA D-0122-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 125 mcg recall — FDA D-0118-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
SEVERE COLD AND FLU PLUS CONGESTION Kirkland Severe Cold & Flu Plus Congestion: Day - 112 recall — FDA D-0115-2025
CGMP Deviations: Released product should have been rejected.
Class IIFDA: TerminatedLNK International, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton recall — FDA D-0132-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton recall — FDA D-0135-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton recall — FDA D-0131-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 50 mcg recall — FDA D-0124-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton recall — FDA D-0136-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton recall — FDA D-0133-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets USP, 100 mcg recall — FDA D-0127-2025
Superpotent Drug and Subpotent Drug: potency failures obtained
Class IIFDA: OngoingViatris Inc
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026370 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026339 records · 4 categoriesApril 2026414 records · 4 categoriesMarch 2026189 records · 4 categoriesFebruary 2026330 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025388 records · 4 categoriesNovember 2025324 records · 4 categoriesOctober 2025454 records · 4 categoriesSeptember 2025180 records · 4 categories